Retapamulin

From WikiMD.org
Jump to navigation Jump to search

Retapamulin

Retapamulin (pronounced reh-tuh-pam-yoo-lin) is a topical antibiotic used in the treatment of skin infections. It is a member of the pleuromutilin class of antibiotics and is primarily used to treat impetigo, a common bacterial skin infection.

Etymology

The name "Retapamulin" is derived from the class of antibiotics it belongs to, pleuromutilin, and its chemical structure. The "Ret" prefix is a reference to its reticulated structure, while "apamulin" is a combination of "pleuromutilin" and "pam", a common suffix in drug nomenclature.

Usage

Retapamulin is used topically, meaning it is applied directly to the skin. It is primarily used to treat impetigo, a skin infection caused by the Staphylococcus aureus or Streptococcus pyogenes bacteria. It may also be used to treat other skin infections as determined by a healthcare provider.

Mechanism of Action

Retapamulin works by inhibiting the synthesis of bacterial proteins, which are necessary for the bacteria to grow and multiply. It does this by binding to the 50S subunit of the bacterial ribosome, preventing the formation of new proteins.

Side Effects

Common side effects of Retapamulin include irritation at the site of application, itching, and redness. More serious side effects can include allergic reactions, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski